These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 18293984)
1. Inhibition of Helicobacter pylori aminoacyl-tRNA amidotransferase by puromycin analogues. Balg C; Huot JL; Lapointe J; Chênevert R J Am Chem Soc; 2008 Mar; 130(11):3264-5. PubMed ID: 18293984 [No Abstract] [Full Text] [Related]
2. Inhibition of Helicobacter pylori aminoacyl-tRNA amidotransferase by chloramphenicol analogs. Balg C; De Mieri M; Huot JL; Blais SP; Lapointe J; Chênevert R Bioorg Med Chem; 2010 Nov; 18(22):7868-72. PubMed ID: 20943400 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Helicobacter pylori Glu-tRNA Pham VH; Maaroufi H; Balg C; Blais SP; Messier N; Roy PH; Otis F; Voyer N; Lapointe J; Chênevert R FEBS Lett; 2016 Oct; 590(19):3335-3345. PubMed ID: 27586694 [TBL] [Abstract][Full Text] [Related]
4. Cyclic peptides identified by phage display are competitive inhibitors of the tRNA-dependent amidotransferase of Helicobacter pylori. Pham VH; Maaroufi H; Levesque RC; Lapointe J Peptides; 2016 May; 79():8-15. PubMed ID: 26976271 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of a GatCAB amidotransferase: aspartyl-tRNA synthetase increases its affinity for Asp-tRNA(Asn) and novel aminoacyl-tRNA analogues are competitive inhibitors. Huot JL; Balg C; Jahn D; Moser J; Emond A; Blais SP; Chênevert R; Lapointe J Biochemistry; 2007 Nov; 46(45):13190-8. PubMed ID: 17929881 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors. Xiao ZP; Peng ZY; Dong JJ; He J; Ouyang H; Feng YT; Lu CL; Lin WQ; Wang JX; Xiang YP; Zhu HL Eur J Med Chem; 2013 May; 63():685-95. PubMed ID: 23567958 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues. Prazeres VF; Tizón L; Otero JM; Guardado-Calvo P; Llamas-Saiz AL; van Raaij MJ; Castedo L; Lamb H; Hawkins AR; González-Bello C J Med Chem; 2010 Jan; 53(1):191-200. PubMed ID: 19911771 [TBL] [Abstract][Full Text] [Related]
8. A quest for novel antimicrobial targets: Inhibition of Asp-tRNA Sangsuwan W; Taweesablamlert A; Boonkerd A; Isarangkool Na Ayutthaya C; Yoo S; Javid B; Faikhruea K; Vilaivan T; Aonbangkhen C; Chuawong P Bioorg Chem; 2024 Sep; 150():107530. PubMed ID: 38852310 [TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization and inhibitor discovery of shikimate dehydrogenase from Helicobacter pylori. Han C; Wang L; Yu K; Chen L; Hu L; Chen K; Jiang H; Shen X FEBS J; 2006 Oct; 273(20):4682-92. PubMed ID: 16972983 [TBL] [Abstract][Full Text] [Related]
10. Characterization of tunnel mutants reveals a catalytic step in ammonia delivery by an aminoacyl-tRNA amidotransferase. Zhao L; Rathnayake UM; Dewage SW; Wood WN; Veltri AJ; Cisneros GA; Hendrickson TL FEBS Lett; 2016 Sep; 590(18):3122-32. PubMed ID: 27500385 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of non-isomerizable analogues of Ala-tRNA(Ala). Mellal D; Fonvielle M; Santarem M; Chemama M; Schneider Y; Iannazzo L; Braud E; Arthur M; Etheve-Quelquejeu M Org Biomol Chem; 2013 Sep; 11(36):6161-9. PubMed ID: 23925523 [TBL] [Abstract][Full Text] [Related]
12. Petrosamine B, an inhibitor of the Helicobacter pylori enzyme aspartyl semialdehyde dehydrogenase from the Australian sponge Oceanapia sp. Carroll AR; Ngo A; Quinn RJ; Redburn J; Hooper JN J Nat Prod; 2005 May; 68(5):804-6. PubMed ID: 15921437 [TBL] [Abstract][Full Text] [Related]
13. Competitive inhibitors of Helicobacter pylori type II dehydroquinase: synthesis, biological evaluation, and NMR studies. Sánchez-Sixto C; Prazeres VF; Castedo L; Suh SW; Lamb H; Hawkins AR; Cañada FJ; Jiménez-Barbero J; González-Bello C ChemMedChem; 2008 May; 3(5):756-70. PubMed ID: 18200648 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of 3-alkyl enol mimics inhibitors of type II dehydroquinase: factors influencing their inhibition potency. Blanco B; Sedes A; Peón A; Lamb H; Hawkins AR; Castedo L; González-Bello C Org Biomol Chem; 2012 May; 10(18):3662-76. PubMed ID: 22447158 [TBL] [Abstract][Full Text] [Related]
17. Discovery of Helicobacter pylori shikimate kinase inhibitors: bioassay and molecular modeling. Han C; Zhang J; Chen L; Chen K; Shen X; Jiang H Bioorg Med Chem; 2007 Jan; 15(2):656-62. PubMed ID: 17098431 [TBL] [Abstract][Full Text] [Related]
18. Preliminary studies into the inhibition of the cholesterol alpha-glucosyltransferase from Helicobacter pylori using azasugars. Gunasekara S; Vrielink A; Stubbs KA Carbohydr Res; 2010 May; 345(7):960-4. PubMed ID: 20307874 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of a diazepanone-based library of liposidomycins analogs as MraY inhibitors. Mravljak J; Monasson O; Al-Dabbagh B; Crouvoisier M; Bouhss A; Gravier-Pelletier C; Le Merrer Y Eur J Med Chem; 2011 May; 46(5):1582-92. PubMed ID: 21377772 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases. Sink R; Kovac A; Tomasić T; Rupnik V; Boniface A; Bostock J; Chopra I; Blanot D; Masic LP; Gobec S; Zega A ChemMedChem; 2008 Sep; 3(9):1362-70. PubMed ID: 18651694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]